Moreover, we assessed the specificity and selectively of CEA-targeted NPs loaded with 5-FU in CMS1 and CMS4 CRC cell lines, as well as their effect on cell metabolic activity inhibition. The gene discussed is CEACAM5; the disease is colorectal carcinoma.